- Open Access
- Open Peer Review
Challenges in defining an optimal approach to formula-based allocations of public health funds in the United States
© Buehler and Holtgrave; licensee BioMed Central Ltd. 2007
- Received: 03 November 2006
- Accepted: 29 March 2007
- Published: 29 March 2007
Controversy and debate can arise whenever public health agencies determine how program funds should be allocated among constituent jurisdictions. Two common strategies for making such allocations are expert review of competitive applications and the use of funding formulas. Despite widespread use of funding formulas by public health agencies in the United States, formula allocation strategies in public health have been subject to relatively little formal scrutiny, with the notable exception of the attention focused on formula funding of HIV care programs. To inform debates and deliberations in the selection of a formula-based approach, we summarize key challenges to formula-based funding, based on prior reviews of federal programs in the United States.
The primary challenge lies in identifying data sources and formula calculation methods that both reflect and serve program objectives, with or without adjustments for variations in the cost of delivering services, the availability of local resources, capacity, or performance. Simplicity and transparency are major advantages of formula-based allocations, but these advantages can be offset if formula-based allocations are perceived to under- or over-fund some jurisdictions, which may result from how guaranteed minimum funding levels are set or from "hold-harmless" provisions intended to blunt the effects of changes in formula design or random variations in source data. While fairness is considered an advantage of formula-based allocations, the design of a formula may implicitly reflect unquestioned values concerning equity versus equivalence in setting funding policies. Whether or how past or projected trends are taken into account can also have substantial impacts on allocations.
Insufficient attention has been focused on how the approach to designing funding formulas in public health should differ for treatment or service versus prevention programs. Further evaluations of formula-based versus competitive allocation methods are needed to promote the optimal use of public health funds. In the meantime, those who use formula-based strategies to allocate funds should be familiar with the nuances of this approach.
- Public Health Program
- Public Health Agency
- Funding Formula
- Formula Allocation
- Competitive Allocation
In 2004, the legislature in state of Louisiana proposed legislation that would mandate the following approach for the regional allocation of funds for public health services related to addictive disorders, developmental disabilities, and mental health. In the proposed legislation, program managers were charged to:
[in the first year of implementation] calculate formulas to adjust raw population data (by age) to account for variations in the incidence/prevalence of disabilities and to adjust for variations in estimated demand for public sector services within...jurisdictions...The formulas shall be based on the most recent reliable scientific information available related to prevalence and demand for services and revised and updated as new research data becomes available... [and in the second year of implementation to] develop budget allocation formulas that incorporate population adjusted per capita funding levels, service access, and service utilization patterns.... The funding formula may also take in account historical funding levels, urban/rural differences in service delivery models and costs, funds reserved for state level administration and planning and state discretionary grants, and such other factors as determined applicable by the offices. When inequities in resource deployment or service access are identified in the regional profiles, then the allocation formulas must include incremental strategies to increase equity of access to services... .
This mandate exemplifies the expectations of political leaders for assuring that public funds are allocated according to need and in ways that support the goals of specific public health programs. Developing a formula that fulfills this mandate would be daunting and raises multiple questions: are timely and accurate data available that reflect the various dimensions of this mandate, how should specific indicators be combined and weighted mathematically, how should inequities in resource use or equity in access to services be defined? If the mix of considerations that shape allocations is too complex or nuanced, then attempting to allocate funds using a formula may not be the optimal approach; and inviting jurisdictions to submit funding requests and justifications that are reviewed by an independent panel of experts may be preferable. State and national public health agencies in the United States employ a combination of these two strategies to allocate program funds .
Controversy and debate can arise whenever public health agencies determine how finite program funds should be allocated among constituent jurisdictions, given the potential for "losers and winners" whenever alternative allocation strategies are considered. Under formula-based methods, the proportion of available resources allocated to each jurisdiction is determined by a mathematical calculation. Under competitive methods, allocations are based on expert review of applications. Competitive awards may be based on a de facto hybrid of qualitative and formulaic indicators, such as quantitative measures of morbidity or mortality used by applicants to justify proposed budgets. The merits of these formula-based versus competitive allocation approaches mirror one another. Formula-based allocations are generally simpler and more transparent, while competitive allocations are better geared to considering the complexities of local circumstances. While the allocation of huge sums is at stake when national and state-level public health programs are considered, there has been relatively little formal evaluation of formula allocation methods used by federal public health programs , with the notable exception of the Ryan White HIV CARE program, which has been the subject of an in-depth assessment by the Institute of Medicine and multiple reviews by the Government Accountability Office and others [3–7]. The purpose of this article is to inform debates regarding the use of formula-based funding methods.
National Academy of Sciences Panel on Formula Allocations
Formula-based funding is used widely by multiple federal government agencies in the United States. Prompted initially by controversies surrounding education program funding, in 2000, the National Academy of Sciences convened a Panel on Formula Allocations, which issued reports in 2001 and 2003 [8, 9]. The panel reported that in fiscal years 1999 and 2000, the federal government distributed over $250 billion using funding formulas. Medicaid, a healthcare insurance program for those who meet certain need or disability criteria, accounted for nearly half of this spending; followed by highway construction, education, and various social service programs. The panel reviewed the elements of formulas, including data sources and statistical methods, as well as the advantages, limits, and unintended consequences of formula allocation methods. The panel concluded its deliberations by recommending that the federal government's Office of Management and Budget establish a standing "Committee on Formula Allocations" to develop "improved simulation and quality-control techniques for use in formula design" and to prepare a handbook for legislators and program managers "that would serve as an introduction to underlying concepts and practical considerations in the use of formula-based fund allocation." . To date, no such office has been established .
The NAS panel observed that funding formulas range from simple to complex, with simple formulas involving a single data source and complex formulas involving multiple data sources and adjustments for differences in the cost of providing services or the availability of local resources . Formulas typically include a minimum funding level guaranteed to all recipients, with or without an eligibility threshold, a funding ceiling, and a "hold-harmless" provision to blunt effects of random fluctuations in source data. The panel concluded that transparency and perceived fairness were major advantages of formula-based allocations. These advantages can be offset if the design and legislative approval of formulas is excessively influenced by advocates from particular jurisdictions, if data sources and calculations imperfectly reflect program goals, if the use of a data source leads to anomalies in how data are collected (especially when funded jurisdictions are responsible for collecting the data), if perceived fairness is undermined by substantial variations in "per capita" or "per eligible" funding due to guaranteed minimums or hold-harmless provisions, or if a lack of clear definitions and procedures creates an appearance of gaming to suit particular jurisdictions. The NAS panel did not substantially consider the potentially unique challenges inherent in funding public health programs aimed at disease prevention. For example, if disease counts are used as the basis for funding a prevention program, an area that is successful in preventing illness could lose funding, threatening its ability to sustain its success. A classic illustration of the phenomenon of program success leading to a decrease in morbidity and a decrease in funding is the erosion of the infrastructure for tuberculosis prevention and control that occurred in the United States in 1970's and early 1980's, only to be followed by a resurgence in tuberculosis in the late 1980s and early 1990s [10, 11]. Recognition of this resurgence prompted renewed support for tuberculosis programs, which enabled successful efforts to reverse unfavorable trends.
Ryan White HIV CARE program formula
Among formulas used by federal public health agencies in the United States, it is not surprising that the formulas used in the various "titles" or components of the Ryan White HIV CARE program have been subject to the greatest scrutiny, given both the role of political advocacy in shaping HIV care programs and controversies surrounding approaches to monitoring the HIV epidemic [7, 12–14]. Evaluations of the Ryan White formula are extensively documented elsewhere [2–7], so we will touch on just a few points from prior reports that illustrate the challenges in designing a funding formula. Foremost is the limitation of the source data relative to program objectives, namely cases of AIDS reported to state health departments . AIDS represents the late stage of HIV disease, but the program aims to serve people at all stages and to encourage early care. This limitation of the source data prompted Congress, when it reauthorized the Act in 2000, to mandate that HIV data be included in formula beginning in FY-2007 [4, 5]. Moreover, program services are intended as a "safety net" for those who cannot otherwise afford care, due to limited or exhausted resources, yet people reported with AIDS include many who would not meet the program's financial eligibility criteria . The formula originally used cumulative numbers of AIDS reports, which eventually included many who had died, prompting a shift to counts of people living with AIDS . The "hold-harmless" provision embedded in this change contributed to substantial variations in "per case" funding, primarily for one geographic area, San Francisco, relative to others [4, 5]. Without this provision, San Francisco, an area with a large and relatively early AIDS epidemic and thus a sizeable number of AIDS deaths, would have lost a substantial share of funding. With this provision, San Francisco receives a much higher "per case" allocation than other areas [4, 5]. Costs for providing HIV care vary among regions of the country, but early efforts to incorporate a cost adjustment in the design of the formula bogged down in Congressional deliberations and were eventually abandoned . Theoretically, a state that is highly successful in providing early HIV care could achieve a reduction in AIDS cases and a reduction in its proportional allocation as a result, although this particular consideration does not appear to have been a major concern in prior deliberations regarding the use of AIDS report data in the formula [2–6].
The Ryan White formula also illustrates the potential hazards of using data collected by grantees. States vary in the quality and completeness of their AIDS surveillance systems, and these variations are even greater for HIV reporting systems [4, 6]. The latter is further complicated by debates surrounding the use of names in HIV reporting systems. While the vast majority of states have adopted name-based HIV reporting systems, a few adhere to the use of systems that employ anonymous coding procedures. To date, CDC has not endorsed the use of non-name systems, and thus states that use such systems are at risk for losing a share of funding, as HIV data are phased into use in the Ryan White formula . Concern about the proposed impact of the pending inclusion of HIV report data in the formula is one reason why the National Alliance of State and Territorial AIDS Directors has proposed delaying the passage of the Ryan White reauthorization bill, pending further assessment of the impact of this and other proposed changes to the program .
Formulas are not as transparent or value-free as they appear
Transparency means that an observer can readily determine how an allocation for a particular area was determined using a formula. This is true, however, only if the formula is carefully documented and the documentation is publicly available. For example, in January 2006, the U.S. Department of Health and Human Services announced plans to disperse approximately $100 million to "accelerate state and local pandemic influenza preparedness efforts" using a formula-based method. A press release described the formula in the following manner:
"...grants will be awarded to all 50 states, 7 territories, the Commonwealth of Puerto Rico, and the District of Columbia. Each state will receive a minimum of $500,000, with additional allocation of funds by population. In addition to the state grants, funds are being awarded to New York City, Chicago and Los Angeles County." .
No further information was released about the specifics of the formula, although a table accompanied the press release showing how much money each state, territory, commonwealth, and separately-funded city or county would receive . From this information alone, it is not possible to re-create the reported allocations because reports about the formula do not specify 1) the source of census data, e.g., 2000 census data or inter-census estimates, with the latter being available on the Bureau of Census Internet site for more recent years for states than for other areas), 2) whether state calculations include or exclude the populations of separately-funded cities, although the latter can be presumed based on approximate calculations with available data, or 3) procedures used to define population-based funding provided to territories. Moreover, no rationale is provided for how either state or territorial baseline levels were determined.
Characteristics of national public health program formulas in the United States
Considerations for future research and evaluation in the design and use of funding formulas
Public health systems research in general and research into optimal public health financing strategies in particular are under-developed areas of inquiry and evaluation . As a result, little practical and evidence-based guidance is available to inform decisions by public health managers regarding whether to allocate funds using a formula-based or competitive approach, or if the formula approach is selected, regarding optimal methods for constructing allocation formulas.
In addition to research that focuses on the utility of specific attributes of funding formulas, attention should also be focused on questions of how the selection of formula options reflects or suits different values or perspectives and on the ways that formulas can be or have been manipulated to suit the interests of particular jurisdictions. There are also underlying ethical questions that merit exploration, such as the weighing the importance of achieving comparable levels of per capita or per case funding (e.g., equity) versus recognizing that different levels of funding may be needed in different areas to achieve comparable results (e.g., equivalency). The recommendation of the National Academy of Sciences panel to develop a guide for those contemplating the use of formula allocations should be considered specifically for public health [8, 9]. Lastly, there may be value in looking beyond the impact of formulas as part of individual programs. For example, how is the overall quality of life or the health of a state affected by the mix of formula-based federal public health programs? In the meantime, those who use formula-based strategies to allocate funds should be familiar with the advantages, limitations, and nuances of this approach.
Public health agencies in the United States often allocate program funds among constituent jurisdictions using either formula-based or competitive methods. Formula-based methods may be simpler or more transparent than competitive allocations, but this appearance may be deceptive and mask underlying values or priorities that shape the selection of formula data sources or calculation methods. The design and use of funding formulas in public health represents an under-developed area of applied, practice-based research. As a result, little evidence-based guidance is available to those who seek to use formula-based allocation methods. Users of this approach should be familiar with its advantages, limits, and nuances.
Dr. Buehler was supported by a Robert Wood Johnson Foundation grant for Public Health Finance: Advancing a Field of Study Through Public Health Systems Research. (Project ID No. 52643). The authors wish to thank Lydia Ogden, MA, MPP, Office of the Chief of Staff, Office of the Director, Centers for Disease Control and Prevention, and Thomas A. Louis, PhD, Professor, Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, President, International Biometric Society, and chair of the National Academy of Sciences Panel on Formula Allocations, for their thoughtful critiques of a draft of the manuscript and their suggestions.
- Louisiana Department of Health and Hospitals: LAC 48:I.Chapter 26. Notice of Intent: Proposed Rule. 2004 Reg. LEXIS. 12674, March 20, 2004Google Scholar
- Buehler JW, Holtgrave DR: Who gets how much: funding formulas in federal public health programs. J Public Health Management Practice. 2007, 13: 151-155. [http://www.jphmp.com/pt/re/jphmp/fulltext.00124784-200703000-00010.htm;jsessionid=FsbT55QD01Tf3p1Hz2V3hSnJgnpyQBqnbyQD1FMK73dd7Dnn11zd!-1412202079!-949856144!8091!-1]View ArticleGoogle Scholar
- United States General Accounting Office: Ryan White CARE Act of 1990: Opportunities to Enhance Funding Equity, November 1995. [http://www.gao.gov/archive/1996/he96026.pdf]
- Committee on the Ryan White CARE Act: Data for Resource Allocation, Planning and Evaluation. Measuring What Matters: Allocation, Planning, and Quality Assessment for the Ryan White CARE Act. 2004, Institute of Medicine of the National Academies Washington, DC: National Academies Press, [http://www.nap.edu/catalog/10855.html#toc]
- United States Government Accountability Office: Ryan White CARE Act: Factors that Impact HIV and AIDS Funding and Client Coverage. Testimony Before the Subcommittee on Federal Financial Management, Government Information, and International Security, Committee on Homeland Security and Governmental Affairs, U.S. Senate. Statement of Marcia Crosse, Director, Health Care. June 23, 2005. GAO-05-841T. Accessed June 7, 2006, [http://www.gao.gov/new.items/d05841t.pdf]
- United States Government Accountability Office: HIV/AIDS: Changes Needed to Improve the Distribution of Ryan White CARE Act and Housing Funds. February 2006. GAO-06-332. Accessed June 7, 2006, [http://www.gao.gov/new.items/d06332.pdf]
- Martin EG, Pollack HA, Paltel AD: Fact, fiction, and fairness: resource allocation under the Ryan White CARE Act. Health Affairs. 2006, 25: 1103-1112. 10.1377/hlthaff.25.4.1103.View ArticlePubMedGoogle Scholar
- Jabine TB, Louis TA, Schirm AL, Eds: Choosing the Right Formula: Initial Report Panel on Formula Allocations. Committee on National Statistics, Division of Behavioral and Social Sciences and Education, National Research Council of the National Academies. 2001, Washington DC: National Academies Press, Accessed June 7, 2006, [http://www.nap.edu/catalog.php?record_id=10178]Google Scholar
- Louis TA, Jabine TB, Gerstein MA, Eds: Statistical Issues in Allocating Funds by Formula. Panel on Formula Allocations, Committee on National Statistics, Division of Behavioral and Social Sciences and Education, National Research Council of the National Academies. 2003, Washington DC: National Academies Press, Accessed June 7, 2006, [http://www.nap.edu/catalog/10580.html#toc]Google Scholar
- Cantrell MF, Snider DE, Cauthen GM, Onorato IM: Epidemiology of tuberculosis in the United States, 1995 through 1992. JAMA. 1994, 272: 535-539. 10.1001/jama.272.7.535.View ArticleGoogle Scholar
- Centers for Disease Control and Prevention: Tuberculosis Elimination Revisited: Obstacles, Opportunities, and a Renewed Commitment – Advisory Council for the Elimination of Tuberculosis (ACET). Morbid Mortal Weekly Rept. 1999, 48 (RR-09): 1-13. [http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4809a1.htm]Google Scholar
- Valdiserri RO: HIV/AID's contribution to community mobilization and health planning efforts. Dawning Answers: How the HIVAIDS Epidemic Has Helped to Strengthen Public Health. Edited by: Valdiserri RO. New York, NY: Oxford University Press, 56-75.Google Scholar
- Buehler JW: HIV and AIDS surveillance: public health lessons learned. Dawning Answers: How the HIVAIDS Epidemic Has Helped to Strengthen Public Health. Edited by: Valdiserri RO. New York, NY: Oxford University Press, 33-55.Google Scholar
- Gostin LO, Ward JW, Baker AC: National HIV case reporting for the United States–a defining moment in the history of the epidemic. NEJM. 1997, 337: 1162-1167. 10.1056/NEJM199710163371611.View ArticlePubMedGoogle Scholar
- National Alliance of State and Territorial AIDS Directors: NASTAD letter to Energy and Commerce Members on RWCA reauthorization. May 24, 2006, [http://www.nastad.org/Programs/publicpolicy/]
- Centers for Disease Control and Prevention: Current Trends Update: Trends in AIDS Diagnosis and Reporting Under the Expanded Surveillance Definition for Adolescents and Adults – United States, 1993. Morbid Mortal Weekly Rept. 1994, 43: 826-831. [http://www.cdc.gov/mmwr/preview/mmwrhtml/00033545.htm]Google Scholar
- Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report. U.S. HIV and AIDS cases reported through December 1994. 1994, 6 (no.2): 1-39. [http://www.cdc.gov/hiv/topics/surveillance/resources/reports/pdf/hivsur62.pdf]Google Scholar
- Centers for Disease Control and Prevention: AIDS cases by state and metropolitan area, provided for the Ryan White CARE Act. HIV/AIDS Surveillance Supplemental Report. 2005, 11 (No. 1): 1-9. [http://www.cdc.gov/HIV/topics/surveillance/resources/reports/2005supp_vol11no1/default.htm]Google Scholar
- U.S. Department of Health and Human Services: HHS Announces $100 Million to Accelerate State and Local Pandemic Influenza Preparedness Efforts. News release, January 12, 2006. [http://www.hhs.gov/news/press/2006pres/20060112.html]
- Honoré PA, Amy BW: Public health finance: advancing a field of study through public health systems research. J Public Health Management Practice. 2005, 11 (6): 571-573.View ArticleGoogle Scholar
- Centers for Disease Control and Prevention: Public Health Emergency Preparedness. Funding Opportunity Number AA154. 2005, [http://www.bt.cdc.gov/planning/guidance05/pdf/annoucement.pdf]Google Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/7/44/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.